Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical Officer

World News: . []

BURNABY British Columbia, March 13 2018 GLOBE NEWSWIRE -- Xenon Pharmaceuticals IncNasdaqXENE a clinical stage biopharmaceutical company, today announced that Dr Ernesto Aycardi will join the company as its Chief Medical Officer CMO providi...

More news and information about Xenon Pharmaceuticals Inc.

Published By:

Globe Newswire: 20:05 GMT Tuesday 13th March 2018

Published: .

Search for other references to "ernesto" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us